EHC vs LH
Encompass Health Corporation and Labcorp Holdings Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | EHC | LH |
|---|---|---|
| Revenue | $5.9B | $14.0B |
| Net income | $566.2M | $876.5M |
| Gross margin | — | 28.8% |
| Net margin | 9.5% | 6.3% |
| Return on equity | 25.1% | 10.5% |
| Diluted EPS | $5.54 | $10.46 |
| Dividend / share | $0.72 | $2.88 |
| Payout ratio | 12.6% | 27.5% |
| Free cash flow | $439.2M | $1.2B |
| Equity | $2.4B | $8.6B |
| Net debt / equity | 0.97× | 0.59× |
| Current ratio | 1.08× | 1.42× |
| Revenue CAGR 5y | 10.7% | −0.0% |
| Profit CAGR 5y | 14.8% | −10.8% |
LH bills 2.4× the revenue of EHC, and EHC keeps more of each dollar of revenue as profit (9.5% against 6.3%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | EHC | LH |
|---|---|---|
| FY2025 | $5.9B | $14.0B |
| FY2024 | $5.4B | $13.0B |
| FY2023 | $4.8B | $12.2B |
| FY2022 | $4.3B | $11.9B |
| FY2021 | $4.0B | $13.1B |
| FY2020 | $3.6B | $14.0B |
| FY2019 | $4.6B | $11.6B |
| FY2018 | $4.3B | $11.3B |
| FY2017 | $3.9B | $10.3B |
| FY2016 | $3.6B | $9.6B |
Net income by year
Bottom line
| Fiscal year | EHC | LH |
|---|---|---|
| FY2025 | $566.2M | $876.5M |
| FY2024 | $455.7M | $746.0M |
| FY2023 | $352.0M | $418.0M |
| FY2022 | $271.0M | $1.3B |
| FY2021 | $412.2M | $2.4B |
| FY2020 | $284.2M | $1.6B |
| FY2019 | $358.7M | $823.8M |
| FY2018 | $292.3M | $883.7M |
| FY2017 | $271.1M | $1.2B |
| FY2016 | $247.6M | $711.8M |
Advertisement
AdSense · Rectangle 336×280